期刊文献+

组合乙肝标志物联合ALT对判断肝损害和HBV-DNA复制状态789例调查分析 被引量:5

Clinical Analysis on HBV Markers, ALT and HBV-DNA for Determination of Hepatic Damage in 789 HBsAg-positive Cases
下载PDF
导出
摘要 目的调查789例乙型肝炎病毒表面抗原(HBsAg)阳性人群的肝损伤及外周血中乙型肝炎病毒复制情况。方法用统计学方法分析HBsAg阳性者789例,同时进行的乙肝标志物五项、ALT和HBV-DNA检验结果分布。结果HBsAg阳性者中ALT异常率为27.8%,而HBV-DNA复制率为49.3%。乙肝标志物组合间的ALT异常率和HBV-DNA复制率存在差异。HBeAg阳性且ALT异常时,HBV-DNA复制率达到93.1%。结论组合乙肝标志物配合ALT可较好地了解肝损伤和HBV-DNA复制情况,有助于判断病情。 objective To investigate the status of liver damage and HBV-DNA replication occurrence in periphery, blood of 789 HBsAg positive cases. Methods The outcomes of five HBV markers (HBVMs) , alanine aminotransferase (ALT) arid HBV-DNA from789 HbsAg-positive eases were statisiieally analyzed together. Results ALT abnormality rate of HbsAg-positive :group was 27.8%,and HBV-DNA replication occurrence rate was 49.3%. Tile rates of ALT abnormality and HBV-DNA replication occurrence were different between the HBVM groups. The HBV-DNA replication occurrence rate in HBeAg-positive and ALT-abnormality group was up to 93.1%.Conclusion The combination of HBVMs and ALT well reflects the status of liver damage and HBV-DNA replication, and it may he helpful to diagnose illness.
出处 《临床军医杂志》 CAS 2009年第1期97-99,共3页 Clinical Journal of Medical Officers
关键词 乙型肝炎病毒 乙肝标志物 ALT HBV-DNA HBV HBV marker alanine aminotransferase HBV-DNA
  • 相关文献

参考文献3

二级参考文献22

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2Scaglioni PP,Melegari M,Wands JR.Biologic properities of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame.Virology,1997,233:374-381.
  • 3Sokal E.Drug treatment of pediatric chronic hepatitis B.Paediatr Drugs,2002,4 (6):361-369.
  • 4Hoofnagle JH,Bisceglie AM.The treatment of chronic viral hepatitis.N Engl J Med,1997,336:347-356.
  • 5Takahashi K,Imai M,Miyakawa Y,et al.Dualty of hepatitis B eantigen in serum of person infected with hepatitis B virus:evidence for the nonidentity of e antigen with immunoglobulins. Proceedings of the National Academy of Sciences of the United States of America . 1978
  • 6Andreone P,Cursaso C,Gramenzi A,et al.A randomwzed controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DN-A-positive chronic hepatitis B. Hepatology . 1996
  • 7Lopez-Alcorocho JM,Cabrerizo M,Bartolome J,et al.Analysis of hepatits B virus precore variants in hepatitis B e antibody-Positive patients treated with prednisone and interferon. Journal of Viral Hepatitis . 1995
  • 8Okamoto H,Akahane Y,Sngai Y,et al.Hepatitis B virus with mutations in the core promotor for an e antigen-negative phenotype in carriers with antibody to e antigen. Journal of Virology . 1994
  • 9Magius LO,Espmark JA.New specificities in Australis antigen positive seradistinct from the Le Bouvier determinants. J Immunol . 1972
  • 10Kosaka Y.Takase K,Kojima M,et al.Fulminant hepatitis B:induction by hepetitis B virus mutations defective in the precore region and incapable of encoding e antgen. Gastroenterology . 1991

共引文献5

同被引文献47

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部